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Angiolymphoid hyperplasia with eosinophilia (ALHE), also known as epitheliod hemangioma is an uncommon benign vascular
tumor of the skin. It usually presents as nodules and erythema over the ears, forehead, or scalp. Histologically, the lesion
is composed of a combination of immature blood vessels, endothelial cells with distinct epitheliod appearance and chronic
inﬂammatory cell inﬁltration with numerous eosinophils. Such a case occurring on the lower lip of a 55-year-old woman is
presented. The lesion was completely excised with clear margins. Surgical resection is the preferred mode of treatment and is
curative.
1.CaseSynopsis
A 55-year-old Caucasian woman presented with a small
painless nodule on her lower lip, which she ﬁrst noticed
for about 10 months previously. On clinical examination,
the nodule was uneven, but not ulcerated and measured
0.5cmindiameter.Thepatientdeniedanyhistoryoftrauma.
Clinical impression was a benign neoplasm, probably a
mucocele. The patient underwent an excisional biopsy of the
lesion.
Microscopically, the lesion showed a well-circumscribed
dermal nodule (Figure 1). The center of the nodule
contained a large number of blood vessels. The endothelial
cells protruded into the lumen causing almost complete
occlusion. These cells showed an epithelioid appearance
with abundant eosinophilic cytoplasm and prominent
nucleoli. In the periphery of these vessels, a noticeable
inﬁltration of lymphocytes, histiocytes, and eosinophils was
seen (Figures 2 and 3) .Af e wr e a c t i v eg e r m i n a lc e n t e r sw e r e
also evident within the inﬁltration (Figure 4). We did not
ﬁnd any artery segment within or in close proximity to the
lesion in multiple deeper sections.
Immunohistochemical stains were performed to identify
the nature of the lesion. The result showed that the epithe-
lioid endothelial cells are strongly positive for endothelial
marker CD31 (Figure 5), but negative for epithelial marker
CK AE1/3 and neuronal marker S-100. The peripheral
lymphocytes showed a mixture of T lymphocytes (CD3
positive) and B cells (CD20 positive).
2.What Is YourDiagnosis?
2.1. Diagnosis. Angiolymphoid hyperplasia with eosino-
philia (Epitheliod hemangioma).
2.1.1. Case Synopsis. A 55-year-old Caucasian female pre-
sented with a small painless nodule on her lower lip, which
she ﬁrst noticed for about 10 months previously. On clinical
examination, the nodule was uneven, but not ulcerated and
measured 0.5cm in diameter. The patient denied any history
of trauma. Clinical impression was a benign neoplasm,
probably a mucocele. The patient underwent an excisional
biopsy of the lesion.
Microscopically, the lesion showed a well-circumscribed
dermal nodule (Figure 1). The center of the nodule con-
tained a group of blood vessels. The endothelial cells
protruded into and almost completely occluded the lumen.
These cells showed an epithelioid appearance with abun-
dant eosin-ophilic cytoplasm and prominent nucleoli. In
the periphery of these vessels, a noticeable inﬁltration of2 Pathology Research International
Figure 1: This is a well-circumscribed dermal nodule composed
of central angiomatous vascular proliferation with stromal and
peripheral inﬁltrates of lymphocytes and eosinophils.
Figure 2: Proliferation of small blood vessels, lined by enlarged
endothelial cells (epitheliod in appearance) with uniform ovoid
nuclei and intracytoplasmic vacuoles.
lymphocytes, histiocytes, and eosinophils was seen (Figures
2 and 3). A few reactive germinal centers were also evident
in the inﬁltration (Figure 4). We did not ﬁnd any artery
segmentwithinorincloseproximitytothelesioninmultiple
deeper sections.
Immunohistochemical stains were performed to identify
the nature of the lesion. The result showed that the epithe-
lioid endothelial cells are strongly positive for endothelial
marker CD31 (Figure 5), but negative for epithelial marker
CK AE1/3 and neuronal marker S-100. The peripheral
lymphocytes showed a mixture of T lymphocytes (CD3
positive) and B cells (CD20 positive).
A diagnosis of ALHE was made. Since the excisional
biopsy margin was clear, no further treatment was recom-
mended. One year later, the patient remained free of any
recurrence.
Figure 3: Prominent eosinophils are displayed amongst the lym-
pocytic presence in the stromal inﬁltrate.
Figure 4: Lymphoid aggregates with follicle formation are identi-
ﬁed amongst the vascular proliferative cells.
3. Discussion
With the general symptom of a nonulcerating, painless
nodule of the lip, the diagnosis of ALHE can be challenging.
Clinically, the diﬀerential diagnosis for a painless nodule of
the lip includes mucocele, lymphocytoma cutis, granuloma
faciale, benign and malignant tumors of skin and adnexal
tissues, and Kimura disease. Excision and submission of
the lesion for histological examination will demonstrate
the presence of blood vessels with epithelioid endothelial
cells in addition to histiocytes, plasma cells, lymphocytes,
and eosinophils. These ﬁndings rule out most diﬀerential
diagnoses, except for Kimura disease.
Kimura disease and ALHE, until recently, were consid-
ered to be diﬀerent stages of the same disease. The separation
of these two disorders occurred as ALHE was found to be a
localized hyperplasia with no systemic involvement. Kimura
disease has been shown to have systemic involvement with
symptoms including lymphadenopathy, blood eosinophilia,
and nephrotic syndrome as a result of IgE deposition in the
renal glomeruli [1]. The histological presentation of Kimura
disease diﬀers from ALHE in two factors. The vascular
proliferation is less prominent than the inﬂammatory cells,Pathology Research International 3
Figure 5: CD 31 stain highlights the endothelial cells, demonstrat-
ing a strong angiogenesis component to the nodule.
and the blood vessels are lined by more attenuated endothe-
lial cells, not epitheliod endothelial cells [2]. The clinical
picture in conjunction with the microscopic examination
and immunohistochemical stains is needed to make the
correct diagnosis.
The etiology of ALHE is unclear. There are currently
manyhypothesesregardingtheoriginofALHE.Somebelieve
it is a reactive process to insect bites [3], hyperestrogen
states [4], or immunologic mechanisms [5]. Multiple studies
have investigated if ALHE is a reactive vascular proliferation
subsequent to inﬂammation associated with traumatized
blood vessels [6]. One study reported a history of trauma
in only 9% of 116 patients with ALHE [7]. Overall, none
of these hypotheses have proven to be a deﬁnitive cause
of ALHE, leaving the commonly held opinion that it is an
idiopathic disorder.
ALHE was originally thought to aﬀect the head or neck
of young women [8]. However, several reviews show a wide
age range of aﬀected persons peaking at 20–50 years without
a sexual predominance [9, 10]. ALHE occurs commonly on
the head and neck with a predilection for the forehead, scalp,
and skin around ears [8–10]. Though rare, this condition has
been reported to occur on the trunk, breast, vulva [11], and
the penis [12]. There have been only three reported cases of
ALHE aﬀecting the lip [13–15].
The presenting history of ALHE is wide ranging. It can
present as asymptomatic, painful, or itchy nodules with
or without erythema. Rarely do the nodules grow larger
than 2-3cm in diameter, pulsate, or bleed. The nodules and
symptoms infrequently spontaneously regress [16]a n dt h u s
require no treatment.
Various treatments have been tried for ALHE. Some
studies have found retinoids to be eﬀective in treating
this disorder due to their ability to decrease keratinocytes’
production of vascular endothelial growth factor, which
inhibits angiogenesis [17]. Retinoid eﬃcacy, similar to all
other medical treatments for ALHE, has shown mixed
results. In addition to side eﬀects, studies demonstrate that
ALHE will often recur with poor compliance or cessation of
medication [18]. The deﬁnitive treatment for this condition
is surgical. Many diﬀerent modalities ranging from carbon
dioxide laser, ultralong pulsed dye laser, to Moh’s surgery
have been suggested [19–21]. The beneﬁt of using laser
therapy is an improved cosmetic outcome, but it requires
multiple treatments and the depth of invasion and size of
the blood vessels can limit the eﬃcacy of the lasers [22].
Lasers with larger wave lengths and longer pulse widths show
much promise in treating ALHE [20]. Excisional therapy is
regarded as the most permanent cure, as was performed in
this case. In particular, Moh’s surgery has shown to be very
eﬀective as it ensures the deﬁnitive removal of arterial and
venous segments at the base of the lesion, decreasing the risk
o fr e c u r r e n c e .O v e r a l l ,t h ed i ﬃculty lies in the diagnosis of
ALHE. Once diagnosed, there are many quality treatments
available to cure this condition.
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